Works matching AU van Dongen, Guus A. M. S.


Results: 76
    1

    <sup>89</sup>Zr-Labeled High-Density Lipoprotein Nanoparticle PET Imaging Reveals Tumor Uptake in Patients with Esophageal Cancer.

    Published in:
    Journal of Nuclear Medicine, 2022, v. 63, n. 12, p. 1880, doi. 10.2967/jnumed.121.263330
    By:
    • Zheng, Kang H.;
    • Kroon, Jeffrey;
    • Schoormans, Jasper;
    • Gurney-Champion, Oliver;
    • Meijer, Sybren L.;
    • Gisbertz, Suzanne S.;
    • Hulshof, Maarten C. C. M.;
    • Vugts, Danielle J.;
    • van Dongen, Guus A. M. S.;
    • Coolen, Bram F.;
    • Verberne, Hein J.;
    • Nederveen, Aart J.;
    • Stroes, Erik S. G.;
    • van Laarhoven, Hanneke W. M.
    Publication type:
    Article
    2

    <sup>89</sup>Zr-labeled High-Density Lipoprotein Nanoparticle PET imaging reveals tumor uptake in patients with esophageal cancer.

    Published in:
    Journal of Nuclear Medicine, 2022, v. 63, n. 10, p. 1, doi. 10.2967/jnumed.121.263330
    By:
    • Zheng, Kang H.;
    • Kroon, Jeffrey;
    • Schoormans, Jasper;
    • Gurney-Champion, Oliver;
    • Meijer, Sybren L.;
    • Gisbertz, Suzanne S.;
    • Hulshof, Maarten C. C. M.;
    • Vugts, Danielle J.;
    • van Dongen, Guus A. M. S.;
    • Coolen, Bram F.;
    • Verberne, Hein J.;
    • Nederveen, Aart J.;
    • Stroes, Erik S. G.;
    • van Laarhoven, Hanneke W. M.
    Publication type:
    Article
    3

    <sup>89</sup>Zr-labeled High-Density Lipoprotein Nanoparticle PET imaging reveals tumor uptake in patients with esophageal cancer.

    Published in:
    Journal of Nuclear Medicine, 2022, v. 63, n. 9, p. 1, doi. 10.2967/jnumed.121.263330
    By:
    • Kang H. Zheng;
    • Kroon, Jeffrey;
    • Schoormans, Jasper;
    • Gurney-Champion, Oliver;
    • Meijer, Sybren L.;
    • Gisbertz, Suzanne S.;
    • Hulshof, Maarten C. C. M.;
    • Vugts, Danielle J.;
    • van Dongen, Guus A. M. S.;
    • Coolen, Bram F.;
    • Verberne, Hein J.;
    • Nederveen, Aart J.;
    • Stroes, Erik S. G.;
    • van Laarhoven, Hanneke W. M.
    Publication type:
    Article
    4

    <sup>89</sup>Zr-labeled High-Density Lipoprotein Nanoparticle PET imaging reveals tumor uptake in patients with esophageal cancer.

    Published in:
    Journal of Nuclear Medicine, 2022, v. 63, n. 7, p. 1, doi. 10.2967/jnumed.121.263330
    By:
    • Zheng, Kang H.;
    • Kroon, Jeffrey;
    • Schoormans, Jasper;
    • Gurney-Champion, Oliver;
    • Meijer, Sybren L.;
    • Gisbertz, Suzanne S.;
    • Hulshof, Maarten C. C. M.;
    • Vugts, Danielle J.;
    • van Dongen, Guus A. M. S.;
    • Coolen, Bram F.;
    • Verberne, Hein J.;
    • Nederveen, Aart J.;
    • Stroes, Erik S. G.;
    • van Laarhoven, Hanneke W. M.
    Publication type:
    Article
    5
    6

    PD-L1 PET/CT imaging with radiolabeled durvalumab in patients with advanced stage non-small cell lung cancer.

    Published in:
    Journal of Nuclear Medicine, 2021, v. 62, n. 11, p. 1, doi. 10.2967/jnumed.121.262473
    By:
    • Smit, Jasper;
    • Borm, Frank J.;
    • Niemeijer, Anna-Larissa N.;
    • Huisman, Marc C.;
    • Hoekstra, Otto S.;
    • Boellaard, Ronald;
    • Oprea – Lager, Daniela E.;
    • Vugts, Danielle J.;
    • van Dongen, Guus A. M. S.;
    • de Wit- van der Veen, Berlinda J.;
    • Thunnissen, Erik;
    • Smit, Egbert F.;
    • de Langen, Adrianus J.
    Publication type:
    Article
    7
    8
    9
    10
    11
    12

    <sup>89</sup>Zr-immuno-PET: towards a non-invasive clinical tool to measure target engagement of therapeutic antibodies in-vivo.

    Published in:
    Journal of Nuclear Medicine, 2019, v. 60, n. 12, p. 1, doi. 10.2967/jnumed.118.224568
    By:
    • Jauw, Yvonne W. S.;
    • O’Donoghue, Joseph A.;
    • Zijlstra, Josée M.;
    • Hoekstra, Otto S.;
    • Willemien Menke-van der Houven van Oordt, C.;
    • Morschhauser, Franck;
    • Carrasquillo, Jorge A.;
    • Zweegman, Sonja;
    • Taskar, Neeta Pandit-;
    • Lammertsma, Adriaan A.;
    • van Dongen, Guus. A. M. S.;
    • Boellaard, Ronald;
    • Weber, Wolfgang A.;
    • Huisman, Marc C.
    Publication type:
    Article
    13
    14
    15
    16
    17
    18

    Three-Dimensional Histologic Validation of High-Resolution SPECT of Antibody Distributions Within Xenografts.

    Published in:
    Journal of Nuclear Medicine, 2014, v. 55, n. 5, p. 830, doi. 10.2967/jnumed.113.125401
    By:
    • Branderhorst, Woutjan;
    • Blezer, Erwin L. A.;
    • Houtkamp, Mischa;
    • Ramakers, Ruud M.;
    • van den Brakel, Jeroen H.;
    • Witteveen, Henry;
    • van der Have, Frans;
    • van Andel, Hugo A. Gratama;
    • Vastenhouw, Brendan;
    • Chao Wu;
    • Stigter-van Walsum, Marijke;
    • van Dongen, Guus A. M. S.;
    • Viergever, Max A.;
    • Bleeker, Wim K.;
    • Beekman, Freek J.
    Publication type:
    Article
    19

    Multicenter Harmonization of <sup>89</sup>Zr PET/CT Performance.

    Published in:
    Journal of Nuclear Medicine, 2014, v. 55, n. 2, p. 264, doi. 10.2967/jnumed.113.130112
    By:
    • Makris, Nikolaos E.;
    • Boellaard, Ronald;
    • Visser, Eric E.;
    • de Jong, Johan R.;
    • Vanderlinden, Bruno;
    • Wierts, Roel;
    • van der Veen, Berlinda J.;
    • Greuter, Henri J. N. M.;
    • Vugts, Danielle J.;
    • van Dongen, Guus A. M. S.;
    • Lammertsma, Adriaan A.;
    • Huisman, Marc C.
    Publication type:
    Article
    20
    21
    22
    23
    24

    <sup>89</sup>Zr-Bevacizumab PET of Early Antiangiogenic Tumor Response to Treatment with HSP90 Inhibitor NVP-AUY922.

    Published in:
    Journal of Nuclear Medicine, 2010, v. 51, n. 5, p. 761, doi. 10.2967/jnumed.109.071043
    By:
    • Nagengast, Wouter B.;
    • de Korte, Maarten A.;
    • Munnink, Thijs H. Oude;
    • Timmer-Bosscha, Hetty;
    • den Dunnen, Wifred F.;
    • Hollema, Harry;
    • de Jong, Johan R.;
    • Jensen, Michael R.;
    • Quadt, Cornelia;
    • Garcia-Echeverria, Carlos;
    • van Dongen, Guus A. M. S.;
    • Hooge, Marjolijn N. Lub-de;
    • Schröder, Carolien P.;
    • de Vries, Elisabeth G. E.
    Publication type:
    Article
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41
    42

    Validation of simplified uptake measures against dynamic Patlak K<sub>i</sub> for quantification of lesional <sup>89</sup>Zr-Immuno-PET antibody uptake.

    Published in:
    European Journal of Nuclear Medicine & Molecular Imaging, 2023, v. 50, n. 7, p. 1897, doi. 10.1007/s00259-023-06151-1
    By:
    • Wijngaarden, Jessica E.;
    • Huisman, Marc C.;
    • Jauw, Yvonne W. S.;
    • van Dongen, Guus A. M. S.;
    • Greuter, Henri N. J. M.;
    • Schuit, Robert C.;
    • Cleveland, Matthew;
    • Gootjes, Elske C.;
    • Vugts, Daniëlle J.;
    • Menke-van der Houven van Oordt, C. Willemien;
    • Boellaard, Ronald
    Publication type:
    Article
    43

    Head-to-head comparison of DFO* and DFO chelators: selection of the best candidate for clinical 89Zr-immuno-PET.

    Published in:
    European Journal of Nuclear Medicine & Molecular Imaging, 2021, v. 48, n. 3, p. 694, doi. 10.1007/s00259-020-05002-7
    By:
    • Chomet, Marion;
    • Schreurs, Maxime;
    • Bolijn, Maria J.;
    • Verlaan, Mariska;
    • Beaino, Wissam;
    • Brown, Kari;
    • Poot, Alex J.;
    • Windhorst, Albert D.;
    • Gill, Herman;
    • Marik, Jan;
    • Williams, Simon;
    • Cowell, Joseph;
    • Gasser, Gilles;
    • Mindt, Thomas L.;
    • van Dongen, Guus A. M. S;
    • Vugts, Danielle J.
    Publication type:
    Article
    44

    Interobserver reproducibility of tumor uptake quantification with <sup>89</sup>Zr-immuno-PET: a multicenter analysis.

    Published in:
    European Journal of Nuclear Medicine & Molecular Imaging, 2019, v. 46, n. 9, p. 1840, doi. 10.1007/s00259-019-04377-6
    By:
    • Jauw, Yvonne W. S.;
    • Bensch, Frederike;
    • Brouwers, Adrienne H.;
    • Hoekstra, Otto S.;
    • Zijlstra, Josée M.;
    • Pieplenbosch, Simone;
    • Schröder, Carolien P.;
    • Zweegman, Sonja;
    • van Dongen, Guus A. M. S.;
    • Menke-van der Houven van Oordt, C. Willemien;
    • de Vries, Elisabeth G. E.;
    • de Vet, Henrica C. W.;
    • Boellaard, Ronald;
    • Huisman, Marc C.
    Publication type:
    Article
    45

    Investigation of the Impact of the H310A FcRn Region Mutation on <sup>89</sup>Zr-Immuno-PET Brain Imaging with a BBB-Shuttle Anti‑Amyloid Beta Antibody.

    Published in:
    Molecular Imaging & Biology, 2024, v. 26, n. 5, p. 823, doi. 10.1007/s11307-024-01931-z
    By:
    • Wuensche, Thomas E.;
    • Stergiou, Natascha;
    • Mes, Iris;
    • Verlaan, Mariska;
    • Kooijman, Esther J. M.;
    • Windhorst, Albert D.;
    • Jensen, Allan;
    • Asuni, Ayodeji A.;
    • Bang-Andersen, Benny;
    • van Dongen, Guus A. M. S.;
    • Vugts, Danielle J.;
    • Beaino, Wissam
    Publication type:
    Article
    46
    47
    48

    Synthesis and preclinical evaluation of [<sup>11</sup>C]EAI045 as a PET tracer for imaging tumors expressing mutated epidermal growth factor receptor.

    Published in:
    EJNMMI Research, 2024, v. 14, p. 1, doi. 10.1186/s13550-024-01078-6
    By:
    • Högnäsbacka, Antonia A.;
    • Poot, Alex J.;
    • Plisson, Christophe;
    • Bergare, Jonas;
    • Bonsall, David R.;
    • McCluskey, Stuart P.;
    • Wells, Lisa A.;
    • Kooijman, Esther;
    • Schuit, Robert C.;
    • Verlaan, Mariska;
    • Beaino, Wissam;
    • van Dongen, Guus A. M. S.;
    • Vugts, Danielle J.;
    • Elmore, Charles S.;
    • Passchier, Jan;
    • Windhorst, Albert D.
    Publication type:
    Article
    49

    Non-specific irreversible <sup>89</sup>Zr-mAb uptake in tumours: evidence from biopsy-proven target-negative tumours using <sup>89</sup>Zr-immuno-PET.

    Published in:
    EJNMMI Research, 2024, v. 14, p. 1, doi. 10.1186/s13550-024-01079-5
    By:
    • Wijngaarden, Jessica E.;
    • Jauw, Yvonne W. S.;
    • Zwezerijnen, Gerben J. C.;
    • de Wit-van der Veen, Berlinda J.;
    • Vugts, Daniëlle J.;
    • Zijlstra, Josée M.;
    • van Dongen, Guus A. M. S.;
    • Boellaard, Ronald;
    • Menke-van der Houven van Oordt, C. Willemien;
    • Huisman, Marc C.
    Publication type:
    Article
    50